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In this  work  we  have  tested  the  in  vivo antiviral  activity  of  type  I interferons  (IFNs)  in  Atlantic  salmon
by  injecting  presmolts  intramuscularly  (i.m.)  with  plasmids  encoding  IFNa1,  IFNb  or IFNc  under  the
control  of a CMV  promoter,  and measured  expression  of antiviral  genes  in  organs  and  protection  against
infection  with  infectious  salmon  anemia  virus  (ISAV)  infection.  All three  IFN  plasmids  induced  expression
of  antiviral  genes  (Mx,  Viperin,  ISG15  and  IFIT5)  at the muscle  injection  site  while  the  control  plasmid
had  little  effect.  Only  IFNb  and  IFNc  plasmids  induced  expression  of  antiviral  genes  in head  kidney,  liver
and  heart.  This  suggests  that  IFNb  and  IFNc  are  distributed  systemically  while  IFNa1  is  active only  at  the
injection  site.  Injection  of IFNc  plasmid  was  found  to induce  expression  of  antiviral  genes and  receptors
for  virus  RNA  (RIG-I,  TLR3  and  TLR7)  in  head  kidney  from  1 to at least  8 weeks.  Immunoblotting  showed
increased  expression  of  ISG15  and  Mx  protein  in liver  with  time  during  this  time  period.  Challenge  of
presmolts  with  ISAV  8 weeks  after injection  of IFN  plasmids,  showed  strong  protection  of the  IFNc  plasmid
injected  ﬁsh,  low  protection  of  the  IFNb  plasmid  injected  ﬁsh  and  no  protection  of  the  IFNa1  plasmid
injected  ﬁsh.  Clues  to  the difference  in  protection  obtained  with  IFNb  and  IFNc  plasmids  were found
by  immunohistochemical  and  immunoblot  studies  of Mx protein,  which  indicated  that  IFNc  plasmid
stimulated  stronger  Mx  protein  expression  in  heart  tissues  and  liver  endothelial  cells  than  IFNb  plasmid.
Taken  together,  these  data  suggest  that  i.m.  injection  of the IFNc  expression  plasmid  may  be a new  method
for  protecting  Atlantic  salmon  against  virus  infection.
ublis©  2014  The  Authors.  P
. Introduction
Farmed Atlantic salmon is attacked by several viruses, which
epresent a continuous threat to the industry. Traditional vaccines
ased on inactivated virus are available for infectious pancre-
tic necrosis virus (IPNV), salmon pancreas disease virus (SPDV)
nd infectious salmon anemia virus (ISAV) and a subunit vaccine
ased on recombinant protein is available for IPNV [1], but these
accines do not appear to give satisfactory protection in the farm-
ng situation. DNA vaccination provides a high level of protection
gainst infectious hematopoietic necrosis virus (IHNV), but not
Abbreviations: IFN, interferon; ISG, interferon-stimulated gene; TLR, Toll-like
eceptor; RIG-I, retinoic acid-inducible protein I; Viperin, virus inhibitory protein
ndoplasmatic reticulum associated interferon-inducible; ISG15, interferon-
nduced protein encoded by the ISG15 gene; IFIT, interferon-induced protein with
etratricopeptide repeats; Mx,  myxovirus resistance; ISAV, infectious salmon ane-
ia  virus; i.m., intramuscular; i.p., intraperitoneally; RT-qPCR, reverse transcription
uantitative PCR; RPS, relative percent survival.
∗ Corresponding author. Tel.: +47 77644487; fax: +47 77644900.
E-mail address: borre.robertsen@uit.no (B. Robertsen).
ttp://dx.doi.org/10.1016/j.vaccine.2014.05.059
264-410X/© 2014 The Authors. Published by Elsevier Ltd. This is an open access article unhed  by  Elsevier  Ltd. This  is an  open  access  article  under  the CC  BY-NC-ND
license  (http://creativecommons.org/licenses/by-nc-nd/3.0/).
other viruses [1]. This calls for improved methods for protection
of farmed salmon against virus diseases.
The discovery of type I IFNs in ﬁsh opens a possibility for using
them in prophylaxis against virus infections in ﬁsh. Type I IFNs are
induced upon host cell recognition of viral nucleic acids [2], and
protect other cells against infection by inducing numerous antiviral
proteins such as Mx,  ISG15, IFIT5 (ISG58) and Viperin [3–5]. In ﬁsh,
four type I IFN subtypes, named IFNa, IFNb, IFNc and IFNd, have so
far been characterized [6,7]. IFNa and IFNd contain 2 cysteines (2C-
IFNs) while IFNb and IFNc contain 4 cysteines (4C-IFNs). The largest
cluster of IFN genes has been found in Atlantic salmon, encoding
two IFNa, four IFNb and ﬁve IFNc genes [6].
Atlantic salmon IFNa, IFNb and IFNc and IFNd have only 22–37%
amino acid sequence identity and show major differences in cellu-
lar expression properties and antiviral activities [6,8]. IFNa1 and
IFNc induced similar strong antiviral activity against IPNV and
induced similar transcript levels of antiviral genes in cell lines, IFNb
was less active and IFNd showed no antiviral activity [8]. IFNa1,
IFNb and IFNc provided only transient inhibition of ISAV replication
in TO cells [9].
In humans, pegylated recombinant IFN-, mostly in combina-
tion with ribavirin, is used for treatment of chronic hepatitis C virus
der the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
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nfections [10]. IFN- treatment has also shown protective effects
gainst inﬂuenza virus infection in mammals and chicken [11–13].
owever, IFN prophylaxis to combat virus diseases in domestic ani-
als and human has apparently had limited success due to the costs
f recombinant IFNs, their rapid degradation in the body and side
ffects. Reports on effects of IFNs against virus infection in live ﬁsh
re scarce. Treatment of rainbow trout with recombinant Atlantic
almon IFNa2 injected intraperitoneally (i.p.) provided protection
gainst IHNV infection for up to 7 days, which is not enough for pro-
hylaxis of farmed ﬁsh [14]. In the present work we have used a
ore novel approach by studying antiviral effects of intramuscular
i.m.) injection of IFN expressing plasmids in Atlantic salmon. The
esults showed surprising differences among IFNa, IFNb and IFNc
lasmids in their ability to induce systemic expression of antiviral
enes and to protect salmon from infection with a high virulent
train of ISAV. Notably, i.m. injection of IFNc plasmid provided sys-
emic up-regulation of antiviral genes in salmon for at least 8 weeks
ccompanied by a high level of protection against ISAV infection.
. Materials and methods
.1. Fish
Atlantic salmon (Salmo salar L.) presmolts (35–45 g) of the strain
quagen standard (Aquagen, Kyrksæterøra, Norway) were kept at
romsø Aquaculture Research Station, Norway in 300 l tanks sup-
lied with fresh water at 10 ◦C and were fed commercial dry food.
rior to treatments, the ﬁsh were anesthetized with 0.005% ben-
ocaine (ACD Pharmaceuticals, Norway). Fish groups were labeled
y tattooing (2% alcian blue, Panjet inoculator). The ﬁsh were killed
y an overdose benzocaine prior to harvest of organs. All handling
f ﬁsh was in accordance with the Norwegian “Regulation on Ani-
al  Experimentation” and all ﬁsh experiments were submitted to
nd approved by the Norwegian Animal Research Authority (NARA)
efore initiation.
.2. Plasmids used for intramuscular injection
Interferon plasmids encoding the open reading frame (ORF) of
tlantic salmon IFNa1, IFNb and IFNc were available from a pre-
ious study [15]. All the three IFN ORFs were sub-cloned into the
cDNA3.3-TOPO vector (Invitrogen) downstream of the CMV  pro-
oter. A religated pcDNA3.3 plasmid without insert was used as
egative control. Plasmids were transformed and grown in One
hot TOP10 Escherichia coli (Invitrogen) and puriﬁed by EndoFree
lasmid puriﬁcation kit (Qiagen).
.3. Antibodies
Polyclonal antibodies against Atlantic salmon Mx  and ISG15 pro-
eins were as described [16,17].
.4. Fish experiments for RT-qPCR, immunoblotting and
mmunohistochemistry
Three experiments were performed where ﬁve groups of pres-
olts kept in one tank were injected intramuscularly (i.m.)
pproximately 1 cm below the dorsal ﬁn with 15 g plasmid in
0 l sterile phosphate-buffered saline (PBS) at pH 7.4 or with PBS
nly. In Experiments 1–3, ﬁsh groups were injected with IFNa1,
FNb or IFNc plasmid or control plasmid. In Experiment 4, ﬁsh
roups were injected with IFNc, control plasmid or PBS. Muscle
issue at the injection site and organs were harvested at differ-
nt time intervals after injection and stored in RNAlater (Ambion)
or RNA extraction or stored in liquid nitrogen for protein extrac-
ion. Experiment 1 (Fig. 1): muscle, head kidney and liver were2 (2014) 4695–4702
harvested 7 days post-injection (dpi) for RT-qPCR (n = 5). Exper-
iment 2 (Figs. 5A, B and 6): at 56 dpi, livers were harvested for
immunoblotting (n = 3) and liver and heart were harvested for
immunohistochemistry (n = 4). Experiment 3 (Fig. 5C): at 14 dpi
heart tissues were harvested for immunoblotting (n = 4). Experi-
ment 4: organs were sampled at 5, 7, 14, 21, 35 and 56 dpi. Muscle
and head kidney were sampled (n = 5) at all time points for RT-
qPCR (Fig. 2A, B and C). Muscle, liver, spleen, gut, heart and gill
were harvested (n = 5) for RT-qPCR at 7 dpi (Supplementary Fig. 2).
Livers were harvested (n = 4) for immunoblotting at 7, 21 and 56 dpi
(Fig. 3).
2.5. Challenge experiment with ISAV
Groups of presmolts (50 ﬁsh per group) kept in one tank were
injected i.m. with IFN plasmids, control plasmid or PBS as described
in 2.3. Eight weeks after injection each ﬁsh was injected i.p. with
100 l L-15 medium containing 104 TCID50 units of the ISAV
Glesvaer/2/90 strain [9]. Mortality was  recorded every day and 28
days post-virus injection relative percentage survival (RPS) in the
groups was calculated as [1 − (% mortality in test group/% mortality
in control plasmid group)] × 100.
2.6. Reverse transcription quantitative PCR (RT-qPCR)
Organ samples or leukocytes were collected in RLT buffer and
RNA was  isolated with the RNeasy Mini kit (Qiagen). One micro-
gram RNA was subjected to cDNA synthesis using QuantiTect
Reverse Transcription Kit (Qiagen). Transcripts of IFNs, Mx,  ISG15,
Viperin, IFIT5 (also named ISG58), RIG-I, TLR7, TLR3 in cDNA from
organs or leucocytes were analyzed by qPCR using 7500 Fast Real-
Time PCR System (Applied Biosystems) as described previously
[15]. Relative quantiﬁcations of gene transcripts were performed
by the Pfafﬂ method [18], using Elongation Factor 1B (EF1B) as
reference gene [19].
2.7. Detection of Mx  and ISG15 protein expression by
immunoblotting
Frozen organs were weighed and transferred to 2 ml  microtubes
and tissue lysis buffer (Tissue Extraction Reagent I, Invitrogen) was
added (100 mg  tissue in 100 l lysis buffer). Homogenization was
performed with Precellys beads and homogenizer (Precellys®24,
Bertin Technologies) at 5900 rpm for 20 s. After centrifugation for
5 min  at 10,000 × g at 4 ◦C, protein concentration in the super-
natants was  measured with BCA protein assay kit (Pierce, Thermo
Science). Supernatants (10 g protein per well) were subjected to
LDS-electrophoresis on a 4–12% NuPAGE Bis-Tris Gel (Invitrogen).
Blotting, antibody incubations and development of blots were done
as described previously [9].
2.8. Detection of Mx protein expression by immunohistochemistry
Organs were ﬁxed in 4% paraformaldehyde in PBS for 24 h at
4 ◦C and embedded in parafﬁn wax by routine procedures. Tissue
sections (4 m)  were cut and mounted onto poly-l-lysine coated
slides, dried and cleared with HistoClear solution (National Diag-
nostics). After rehydration, slides were boiled in 10 mM sodium
citrate buffer (pH 6.0) for 30 min  followed by incubation in 1%
hydrogen peroxide for 15 min. The slides were blocked with 5%
nonfat dried milk powder (AppliChem) for 2 h and subsequently
incubated with anti-Mx antibody (1:500) for 16 h at 4 ◦C and with
HRP-conjugated antibody (1:2000, goat anti-rabbit IgG, Invitrogen)
for 1 h. Red color showing Mx  staining was developed by incuba-
tion with 100 l AEC Substrate Chromogen (Dako) for 10 min  and
the sections were then counterstained with Mayer’s hematoxylin
(Sigma).
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Fig. 1. Induction of antiviral genes in salmon presmolts after i.m. injection of IFN expression plasmids. Five groups of presmolts were injected i.m. with PBS, control plasmid
(CP)  or plasmids expressing IFNa1, IFNb or IFNc, respectively (n = 5). Expression of IFNa1, IFNb, IFNc, Mx, Viperin, ISG15 and IFIT5 was measured by RT-qPCR 7 days after
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anjection. A and B, muscle tissue at the plasmid injection site. C and D, head kidney. E
bundance compared to the Elongation Factor 1B reference gene, while other va
sh.  Statistical signiﬁcant differences (p < 0.05) between IFN plasmid groups and co
.9. Statistical analysis
Statistical analyses were performed using GraphPad Prism
ision 6.01 for Windows. Gene transcripts in organs or leukocytes
ere compared using an unpaired Student’s t-test and considered
s statistically signiﬁcant at p ≤ 0.05. The differences in mortality
nd survival rate were compared using chi square test and consid-
red as statistically signiﬁcant at p ≤ 0.01.
. Results
.1. Expression of antiviral genes in organs after intramuscular
i.m.) injection with IFN expression plasmids
As expected i.m. injection of expression plasmids for IFNa1,
FNb and IFNc into Atlantic salmon presmolts resulted in strong
xpression of the respective IFNs in the muscle tissue (Fig. 1A).
onsequently, all three IFN plasmids caused strong induction of the
ntiviral genes Mx,  Viperin, ISG15 and IFIT5 at the muscle injection, liver. Transcription of IFNa, IFNb and IFNc in muscle is presented as relative mRNA
re presented as fold increase in transcripts (mean ± SD) compared to PBS injected
lasmid group are indicated with a star (*).
site (Fig. 1B). This is most likely due to release of IFN from mus-
cle cells that have taken up plasmid, since transfection of the IFN
expression plasmids into HEK293 cells resulted in secretion of func-
tional IFNs [8]. IFNa1 plasmid seemed to have a somewhat stronger
effect compared to the IFNb and IFNc plasmids, which had similar
effects.
Interestingly, i.m. injections of both IFNb and IFNc plasmids also
caused up-regulation of the antiviral genes in head kidney (Fig. 1D)
and liver (Fig. 1F) whilst neither IFNa1 nor control plasmid had any
effect. Similar results have been observed in four independent ﬁsh
experiments. Injections of IFNb and IFNc plasmids caused a minor
up-regulation of IFNa and IFNb in head kidney while IFNc expres-
sion was  unchanged (Fig. 1C). None of the IFNs were up-regulated
in liver by injections of the IFN-plasmids (Fig. 1E). Taken together,
this suggests that i.m. injection of IFNb and IFNc plasmids cause
systemic up-regulation of antiviral genes due to release of IFNs at
the muscle injection site while IFNa1 plasmid only up-regulates
ISGs at the injection site. Mx  expression was compared in several
organs of ﬁsh 7 days after injection of IFNc plasmid, which showed
4698 C.-J. Chang et al. / Vaccine 32 (2014) 4695–4702
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0ig. 2. Time course study of IFNc and ISGs transcript levels in ﬁsh injected with IFNc
issue  at the plasmid injection site. (B) Expression of antiviral genes in head kidney
T-qPCR at the indicated days post-injection. Values are fold increase in transcripts
lasmid group.
ighest increase in liver followed by heart, head kidney, spleen, gut
nd gills (Suppl. Fig. 1).
Supplementary Fig. 1 related to this article can be found,
n the online version, at http://dx.doi.org/10.1016/j.vaccine.2014.
5.059.id, control plasmid or PBS. (A) Expression of IFNc, Mx,  Viperin and ISG15 in muscle
pression of viral RNA receptors in head kidney. Gene expression was measured by
ared to PBS injected ﬁsh (n = 5). Black bars: IFNc plasmid group, white bars: control
3.2. Effect of IFNa1 and IFNc on expression of ISGs in head kidney
leucocytes
Since the IFNc plasmid, but not the IFNa1 plasmid induced
expression of ISGs in head kidney, we wanted to study if
C.-J. Chang et al. / Vaccine 32 (2014) 4695–4702 4699
Fig. 3. Time course study of Mx  and ISG15 protein expression in liver of presmolts injected i.m. with IFNc plasmid, control plasmid or PBS. Liver tissues were harvested
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induced different levels of antiviral proteins in liver and heart,
which are strongly affected by ISAV infection. Immunoblotting of
Mx and ISG15 were used for this purpose. As shown in Fig. 5A and
B, ﬁsh injected with IFNb and IFNc plasmids showed similar strong
Fig. 4. Effect of IFN plasmids on protection of salmon against infection by ISAV.t  7, 21 and 56 days after injection and analyzed for Mx  and ISG15 expression by
roup (lanes 1–4), IFNc plasmid group (lanes 5–8) and control plasmid group (CP, la
nti-actin antibody and are representative of two independent experiments.
ecombinant IFNa1 and IFNc might have different effects on
nduction of ISGs in head kidney leucocytes. However, recombi-
ant IFNa1 and IFNc up-regulated the antiviral genes Mx,  ISG15,
iperin and IFIT5 (ISG58) to similar extents in head kidney leuco-
ytes (Suppl. Fig. 2A). Moreover, IFNa1 and IFNc also up-regulated
imilarly the viral RNA receptors RIG-I, TLR3 and TLR7, which
ctivate IFN transcription upon binding of virus RNA (Suppl. Fig.
B). Lack of systemic induction of ISGs by IFNa1 plasmid is thus
ot likely to be due to lack of response to IFNa1 in organs.
Supplementary Fig. 2 related to this article can be found, in the
nline version, at http://dx.doi.org/10.1016/j.vaccine.2014.05.059.
.3. Time course study of antiviral gene expression in muscle and
ead kidney after injection of IFNc plasmid
To study if i.m. injection of IFNc plasmid had a prolonged effect
n expression of antiviral genes in salmon, groups of presmolts
ere i.m. injected with IFNc plasmid, control plasmid or PBS and
easured for gene transcripts in muscle at the injection site and
ead kidney for a period of 5–56 days. IFNc, Mx,  Viperin and ISG15
xpression were increased in muscle of IFNc plasmid injected ﬁsh
hroughout the experimental period (Fig. 2A). IFNc showed high-
st expression in muscle at day 14 after injection and a declining
xpression in the follow sampling days. Mx  expression in muscle of
FNc plasmid injected ﬁsh was highest at day 7 and then declined
hile ISG15 was elevated through day 35 and declined at day 56.
x expression in head kidney was highest at day 7, declined to a
ow level at day 14 and then gradually increased (Fig. 2B). A similar
rend of expression in head kidney was found for ISG15, IFIT5 and
iperin, and the virus RNA receptors RIG-I, TLR3 and TLR7 (Fig. 2C).
.4. Time course study of Mx  protein expression in liver after
njection of IFNc plasmid
Since we observed increased ISG levels in head kidney through-
ut the 56 days after injection of IFNc plasmid, we wanted to study
SG protein levels in internal organs. For this purpose, we  performed
mmunoblotting of Mx  and ISG15 proteins in liver at 7, 21 and 56
ays after i.m. injection of IFNc plasmid, control plasmid and PBS.
s shown in Fig. 3, Mx  protein was hardly detected in liver from
ontrol plasmid and PBS injected ﬁsh at any time point. In contrast,
x protein was detected in liver of all 4 individuals 7 days after
njection of IFNc plasmid and increased at day 21 and 56. A similar
ncrease in expression pattern was observed for ISG15 (Fig. 3).
.5. Effect of IFN plasmids on protection of salmon against
nfection by ISAV
Since injection of IFNb and IFNc plasmid induced antiviral genes
ystemically in Atlantic salmon, we wanted to ﬁnd out if the IFN
lasmids might provide protection of salmon against virus infec-
ion. For this purpose we chose to challenge the ﬁsh with a high
irulent strain of the orthomyxovirus ISAV, which is known to cause
 high level of mortality in salmon in challenge experiments [20].noblotting. Gels were loaded with 10 g protein from each of four ﬁsh from PBS
–12). Blots were incubated with anti-Mx and anti-actin antibody or anti-ISG15 and
Groups of presmolts were injected i.m. with IFNa1 plasmid, IFNb
plasmid, IFNc plasmid, control plasmid or PBS and kept in a fresh
water tank for 8 weeks before injection with 104 TCID50 Units of
ISAV4. Mortality started to develop at day 16 post-infection and
reached 82% and 91% in the PBS and control plasmid groups, respec-
tively, at day 28 when the experiment was  terminated (Fig. 4). The
mortality in the IFNa1 plasmid injected ﬁsh developed at a similar
rate as in the control groups and reached 86% while the mortality
in the IFNb plasmid injected ﬁsh developed somewhat slower and
reached 75%, which gives a relative percent survival (RPS) of 5.5%
(IFNa) and 17.6% (IFNb) (p > 0.05). In contrast to the other groups,
the IFNc group did not show mortality until day 26 and reached
a total mortality of only 6% at the end of the experiment, which
gives a RPS of 93.4% (p < 0.01). Similar results were obtained in
another challenge experiment. These experiments thus conﬁrmed
the antiviral gene results, which suggested that injection of IFNa1
plasmid does not provide systemic protection of salmon against
virus infection while injection of IFNc plasmid gives a high level
of protection even after 8 weeks. Surprisingly, however, the IFNb
plasmid only provided a low level of protection despite the fact that
it also caused systemic induction of antiviral genes.
3.6. Comparison of antiviral protein expression in liver and heart
after injection of IFN plasmids
As the IFN plasmids showed such a large difference in pro-
tective effect 8 weeks after injection, we  wanted to study if theyGroups of presmolts (n = 50) were injected i.m. with IFNa1 plasmid, IFNb plasmid,
IFNc plasmid, control plasmid or PBS. Eight weeks after injection the ﬁsh were
injected i.p. with 104 TCID50 units of ISAV. Mortality in the groups was  recorded each
day from 1 to 28 days after injection and RPS was calculated from the cumulative
mortality at day 28.
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Fig. 5. Immunoblotting of Mx and ISG15 protein in liver and heart of presmolts after
i.m. injection of IFNa1, IFNb, IFNc or control plasmid. Liver tissues were harvested
at  day 56 after injection and analyzed for Mx  (A) and ISG15 (B). Lanes 1–3: control
plasmid (CP). Lanes 4–6: IFNa1 plasmid. Lanes 7–9: IFNb plasmid. Lanes 10–12: IFNc
plasmid. Non-speciﬁc binding with the anti-ISG15 antibody was observed with a
90  kDa protein band (indicated with *) in all ﬁsh samples. (C) Heart tissues were
harvested at 14 days after injection and analyzed for Mx  expression. Lane 1: Control
plasmid (CP). Lanes 2–5: IFNa1 plasmid. Lanes 6–9: IFNb plasmid. Lanes 10–13: IFNc
plasmid. Each lane was  loaded with 10 g protein from one individual except lane 1
in  (C), which represents pooled protein extracts from four ﬁsh injected with control
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despite the fact that IFNb and IFNc plasmids induced comparable
amounts of Mx  and ISG15 protein in liver 8 weeks after injection.lasmid. Actin was  used as a control for equal loading of protein.
xpression of Mx,  free ISG15 or ISG15 conjugates in liver 8 weeks
fter injection while ﬁsh injected with IFNa1 plasmid or control
lasmid showed faint or no expression of these proteins. These data
id thus not resolve the difference in protection obtained with the
FNb and IFNc plasmids. However, IFNc plasmid induced a higher
evel of Mx  protein in heart compared to IFNb plasmid although this
xperiment was conducted 14 days after plasmid injection (Fig. 5C).
x protein was at similar low levels in heart of ﬁsh injected with
FNa1 and control plasmid.
.7. Immunohistochemistry of Mx  protein in heart and liver from
sh injected with IFNa1, IFNb and IFNc plasmids
The difference in protective effects between IFNb and IFNc plas-
ids might be due to differences in induction of antiviral proteins
n cell types, which are important for ISAV infectivity. Accordingly,
e decided to do immunohistochemistry of Mx  protein in liver and
eart of ﬁsh 8 weeks after injection with PBS or IFNa1, IFNb and
FNc plasmids (Fig. 6). Mx-staining was observed throughout the
iver tissue from IFNb and IFNc treated ﬁsh (Fig. 6C and D) while
ittle Mx-staining was seen in liver of PBS and IFNa1 treated ﬁsh
Fig. 6A and B). In the IFNb and IFNc groups, Mx  was relatively
trongly stained in some cells resembling mammalian Kuppfer cells
nd more weakly stained in hepatocytes. Interestingly, endothelial
ells of blood vessels appeared to be more strongly stained for Mx
n liver from ﬁsh treated with IFNc plasmid than from ﬁsh treated
ith IFNb plasmid. In heart, stratum compactum and stratum spon-
iosum was strongly stained in IFNc plasmid treated ﬁsh (Fig. 6H),
ut more weakly stained in ﬁsh treated with IFNb plasmid (Fig. 6G).
eart from ﬁsh treated with PBS or IFNa1 plasmid showed little or
o staining (Fig. 6E and F).2 (2014) 4695–4702
4. Discussion
Previous work has shown that recombinant IFNa1, IFNb and IFNc
protect salmon cells against IPNV and ISAV infection in vitro, IFNa1
and IFNc having similar and stronger antiviral activity than IFNb
[8,9]. In the present work we  have studied in vivo antiviral activity of
these IFNs delivered as genes in expression plasmids injected i.m.,
which demonstrated that IFNb and IFNc plasmids, but not IFNa1
plasmid induced systemic up-regulation of antiviral genes in live
Atlantic salmon. Notably, only i.m. injection of IFNc plasmid pro-
vided a high level of protection of Atlantic salmon against infection
by a high virulent strain of ISAV for at least 8 weeks after injection.
The fact that all three IFN expression plasmids induced simi-
lar levels of ISG transcripts at the muscle injection site, suggests
that similar amounts of IFNa1, IFNc and IFNb were produced by
the muscle cells. In contrast, only IFNb and IFNc plasmids induced
antiviral genes in head kidney, liver and heart. The lack of induction
of antiviral genes by IFNa1 plasmid injection is not due to lack of
effect of IFNa1 on head kidney cells, since recombinant IFNa1 and
IFNc induced similar levels of ISG transcripts in head kidney leuco-
cytes. These results thus suggest that IFNc and IFNb are distributed
through the circulation and induce antiviral genes systemically in
the ﬁsh while IFNa is only active at the production site. During
a virus infection, IFNa is thus probably mainly important at the
virus infection site while IFNc and IFNb may  be distributed systemi-
cally and trigger synthesis of antiviral proteins in cells throughout
the ﬁsh body. In this context IFNc appears to be a main player in
innate antiviral responses of Atlantic salmon since it is produced
by a variety of cell types, is induced by both viral dsRNA and ssRNA
analogs and has equally strong antiviral activity as IFNa1 [8]. While
IFNb is also distributed systemically, it has less antiviral activity
than IFNa and IFNc, is produced mainly by specialized leukocytes
and was  mainly induced by the ssRNA analog [8]. The difference
in distribution properties of IFNa compared to IFNb and IFNc may
have several explanations. The number of disulphide bridges might
possibly inﬂuence the degradation rate of the IFNs. IFNa is a 2C-
IFN, which contains one disulphide bridge, while IFNb and IFNc
are 4C-IFNs, which contain two  disulphide bridges [21]. However,
the isoelectric points of IFNa1 (pI  9.2) and IFNb/IFNc (pI  6.9/pI 5.1)
are also quite different and might inﬂuence their distribution and
degradation properties.
The time course study showed that IFNc plasmid induced up-
regulation of not only antiviral genes (Mx, ISG15, Viperin, IFIT5),
but also genes for receptors of virus RNA (RIG-I, TLR3 and TLR7) in
head kidney throughout the 8 week experimental period. This sug-
gests that ﬁsh injected with IFNc plasmid indeed possess increased
innate immunity to virus infection compared to ﬁsh injected with
IFNa1 or control plasmid. Increased expression of Mx  and ISG15
protein was conﬁrmed both in liver and heart of IFNc plasmid
injected ﬁsh 8 weeks after injection. It is thus highly likely that
injected IFNc plasmid may  continue to provide systemic expres-
sion of antiviral genes beyond the 8 weeks experimental period.
This ﬁnding inspired us to investigate if injection of IFNc plasmid
might in fact provide protection of Atlantic salmon against virus
infection even at 8 weeks after plasmid injection. For this purpose
we chose a high virulent strain of ISAV, which is an orthomyxovirus
that causes high mortality in Atlantic salmon presmolts. The chal-
lenge experiment indeed showed that IFNc provided a high level
of protection against ISAV induced mortality in salmon 8 weeks
after plasmid injection while IFNa1 and control plasmid provided
no protection compared to PBS injected ﬁsh. Surprisingly, injection
of IFNb plasmid gave a low level of protection against ISAV infectionThis may  be due to that IFNb and IFNc use different receptors and
consequently induce antiviral proteins in different cell types. This
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gig. 6. Immunohistochemistry of Mx  protein in liver and heart 8 weeks after i.m. in
lasmid (B), IFNb plasmid (C) and IFNc plasmid (D). Heart sections from ﬁsh injected
olor  shows staining for Mx  protein. Arrows indicate macrophage like cells in (C) an
dea was examined by immunohistochemistry of Mx protein in
eart and liver, which are strongly affected by ISAV infection. Focal
ecrosis in liver of ISAV infected ﬁsh is commonly found, but the
ain target cells for infection by ISAV are endothelial cells lining
he circulatory system and not hepatocytes [22]. Sections of liver
rom IFNb and IFNc treated ﬁsh showed similar Mx-staining except
hat endothelial cells appeared to be more strongly stained in IFNc
reated ﬁsh compared to IFNb treated ﬁsh. This may  thus in part
xplain the differences in protection obtained with IFNc compared
o IFNb plasmid. Moreover, heart tissue showed stronger Mx  stain-
ng throughout in ﬁsh treated with IFNc plasmid compared to IFNb
lasmid, which was conﬁrmed by immunoblotting of Mx.  This sug-
ests that IFNc induces antiviral proteins more strongly than IFNb inn of IFN plasmids. Liver sections from ﬁsh injected with control plasmid (A), IFNa1
 control plasmid (E), IFNa1 plasmid (F), IFNb plasmid (G) and IFNc plasmid (H). Red
othelial cells in (D), which show strong staining for Mx protein.
several different cell types in heart. Other explanations may, how-
ever, also be possible since mammalian type I IFNs are known to
have a wide range of biological activities such as sensitizing cells
to apoptosis upon subsequent viral infection [23], stimulation of
cytotoxic activity of NK cells [24] and stimulation of cells involved
in adaptive immune responses [25]. The difference in effect of IFNb
and IFNc may  be due to differences in use of receptors, which is
currently under investigation by our group.
Whether i.m. injection of IFNc plasmid might be a usable method
for combating virus infections in farmed salmon depends on sev-
eral questions, which have to be answered in future studies. Among
those are the duration of the antiviral effects of IFNc plasmid
injection, whether IFNc plasmid protects against other viruses
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nd eventual side effects. For example, it needs to be examined
f IFNc plasmid injection affects the general performance of the
sh such as growth and smoltiﬁcation. In such studies the level
f IFNc expression may  be controlled by the plasmid dose and/or
y using promoters other than the CMV  promoter. The beneﬁt
f using IFNc plasmid in prophylaxis against virus infections is
hat it induces antiviral genes with a broad spectrum of antivi-
al properties while conventional DNA vaccines are designed to
nduce adaptive immune responses that are directed toward spe-
iﬁc pathogens.
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